Latest News – Prometheus Laboratories

About Us
Disease Areas & Tests
- Innovative Diagnostic Portfolio to Manage the Patient Journey
  
  Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
- Inflammatory
  Bowel Disease
  
  Monitr Crohn’s Disease
  IBD sgi Diagnostic
  Crohn’s Prognostic
  RiskImmune
  
  Celiac
  
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Therapeutic
  Drug Monitoring
  
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
  
  Liver
  
  FIBROSpect HCV
  FIBROSpect Nash
- Thiopurine
  Management
  
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
  
  Lactose
  Sensitivity
  
  LactoTYPE
- Inflammatory Bowel Disease
  Monitr Crohn’s Disease
  RiskImmune
  IBD sgi Diagnostic
  Crohn’s Prognostic
- Therapeutic Drug Monitoring
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
- Thiopurine Management
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
- Celiac
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Liver
  FIBROSpect HCV
  FIBROSpect NASH
- Lactose Sensitivity
  LactoTYPE
Pipeline
Healthcare Providers
Patients

About Us
Disease Areas & Tests
- Innovative Diagnostic Portfolio to Manage the Patient Journey
  
  Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
- Inflammatory
  Bowel Disease
  
  Monitr Crohn’s Disease
  IBD sgi Diagnostic
  Crohn’s Prognostic
  RiskImmune
  
  Celiac
  
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Therapeutic
  Drug Monitoring
  
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
  
  Liver
  
  FIBROSpect HCV
  FIBROSpect Nash
- Thiopurine
  Management
  
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
  
  Lactose
  Sensitivity
  
  LactoTYPE
- Inflammatory Bowel Disease
  Monitr Crohn’s Disease
  RiskImmune
  IBD sgi Diagnostic
  Crohn’s Prognostic
- Therapeutic Drug Monitoring
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
- Thiopurine Management
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
- Celiac
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Liver
  FIBROSpect HCV
  FIBROSpect NASH
- Lactose Sensitivity
  LactoTYPE
Pipeline
Healthcare Providers
Patients

About Us
Disease Areas & Tests
- Innovative Diagnostic Portfolio to Manage the Patient Journey
  
  Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
- Inflammatory
  Bowel Disease
  
  Monitr Crohn’s Disease
  IBD sgi Diagnostic
  Crohn’s Prognostic
  RiskImmune
  
  Celiac
  
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Therapeutic
  Drug Monitoring
  
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
  
  Liver
  
  FIBROSpect HCV
  FIBROSpect Nash
- Thiopurine
  Management
  
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
  
  Lactose
  Sensitivity
  
  LactoTYPE
- Inflammatory Bowel Disease
  Monitr Crohn’s Disease
  RiskImmune
  IBD sgi Diagnostic
  Crohn’s Prognostic
- Therapeutic Drug Monitoring
  Anser IFX
  Anser ADA
  Anser VDZ
  Anser UST
- Thiopurine Management
  TPMT Genetics
  TPMT Enzyme
  Thiopurine Metabolites
- Celiac
  Celiac Plus
  Celiac Genetics
  Celiac Serology
- Liver
  FIBROSpect HCV
  FIBROSpect NASH
- Lactose Sensitivity
  LactoTYPE
Pipeline
Healthcare Providers
Patients

Prometheus Laboratories Announces New Agreement with MultiPlan, Expanding Patient Access to Specialized GI Testing

News & Events [...]

Prometheus Laboratories Announces New Agreement with MultiPlan, Expanding Patient Access to Specialized GI Testingprometheuslabs2021-07-07T17:01:36-07:00

Prometheus Laboratories Announces Multiple Presentations on Precision-Guided Dosing and Monitoring at the Digestive Disease Week 2021 Annual Meeting

News & Events [...]

Prometheus Laboratories Announces Multiple Presentations on Precision-Guided Dosing and Monitoring at the Digestive Disease Week 2021 Annual Meetingprometheuslabs2021-05-25T18:21:45-07:00

Innovative Diagnostic Portfolio to Manage the Patient Journey

Inflammatory Bowel Disease

Celiac

Therapeutic Drug Monitoring

Liver

Thiopurine Management

Lactose Sensitivity

Innovative Diagnostic Portfolio to Manage the Patient Journey

Inflammatory Bowel Disease

Celiac

Therapeutic Drug Monitoring

Liver

Thiopurine Management

Lactose Sensitivity

Innovative Diagnostic Portfolio to Manage the Patient Journey

Inflammatory Bowel Disease

Celiac

Therapeutic Drug Monitoring

Liver

Thiopurine Management

Lactose Sensitivity

Prometheus Laboratories Announces New Agreement with MultiPlan, Expanding Patient Access to Specialized GI Testing

Prometheus Laboratories Announces Multiple Presentations on Precision-Guided Dosing and Monitoring at the Digestive Disease Week 2021 Annual Meeting

Inflammatory
Bowel Disease

Therapeutic
Drug Monitoring

Thiopurine
Management

Lactose
Sensitivity

Inflammatory
Bowel Disease

Therapeutic
Drug Monitoring

Thiopurine
Management

Lactose
Sensitivity

Inflammatory
Bowel Disease

Therapeutic
Drug Monitoring

Thiopurine
Management

Lactose
Sensitivity